Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan and Amlodipine Extension in Hypertension
NCT00170976Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valsartan, amlodipine in hypertension (HTN), sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00170976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170976.